Publications
All publications
From point A to the sculpted pear: MR image guidance significantly improves tumour dose and sparing of organs at risk in brachytherapy of cervical cancer
Tanderup K et al. Radiother Oncol. 2010 Feb 4.
Tanderup K, Nielsen SK, Nyvang GB, Pedersen EM, Røhl L, Aagaard T, Fokdal L, Lindegaard JC.
Radiother Oncol. 2010 Feb 4. [Epub ahead of print]
20138380
Reduction of Cone-Beam CT scan time without compromising the accuracy of the image registration in IGRT
Westberg J et al. Acta Oncol. 2010;49(2):225-9
Westberg J, Jensen HR, Bertelsen A, Brink C
Acta Oncol. 2010;49(2):225-9
20100157
Real-time dynamic MLC tracking for inversely optimized arc radiotherapy
Falk M. et al. Radiother Oncol. 2010 Jan 18.
Falk M, Af Rosenschöld PM, Keall P, Cattell H, Cho BC, Poulsen P, Povzner S, Sawant A, Zimmerman J, Korreman S.
Radiother Oncol. 2010 Jan 18. [Epub ahead of print]
20089322
Outcome in intermediate or high risk prostate cancer patients receiving radiation dose and hormone therapy
Karlsdottir, A et al. Outcome in intermediate or high risk prostate cancer patients receiving radiation dose and hormone therapy. Acta Oncol. 2009;48(6):874-81
Karlsdottir A, Muren LP, Wentzel-Larsen T, Johannessen DC, Haukaas SA, Halvorsen OJ, Dahl O
Acta Oncol. 2009;48(6):874-81
19488886
Stereotactic body radiotherapy for unresectable cholangiocarcinoma
Kopek N. et al Stereotactic body radiotherapy for unresectable cholangiocarcinoma. Radiother Oncol. 2010 Jan;94(1):47-52.
Kopek N, Holt MI, Hansen AT, Høyer M
Radiotherapy and Oncology 94 (2010) 47–52
19963295
Time-resolved in vivo luminescence dosimetry for online error detection in pulsed dose-rate brachytherapy
Med Phys. 2009 Nov;36(11):5033-43
Andersen CE, Nielsen SK, Lindegaard JC, Tanderup K
Med Phys. 2009 Nov;36(11):5033-43
19994514
Individualization of adaptive PTV's
A method to individualize adaptive planning target volumes for deformable targets
Wright P, Redpath AT, Høyer M, Muren LP
Phys Med Biol. 2009 Dec 7;54(23):7121-7133.
19904035
HPV-associated p16-expression and response to hypoxic modification of radiotherapy in head and neck cancer
Lassen P. et al. HPV-associated p16-expression and response to hypoxic modification of radiotherapy in head and neck cancer. Radiotherapy and Oncology 94 (2010) 30–35
Lassen P, Eriksen JG, Hamilton-Dutoit S, Tramm T, Alsner J, Overgaard J;
Radiotherapy and Oncology 94 (2010) 30–35
19910068
Chemoradiotherapy of head and neck cancer – Can the bumble bee fly?
Editorial in Radiotherapy and Oncology by Jens Overgaard.
Overgaard J.
Radiother Oncol. 2009 Jul;92(1):1-3.
19539125